SynthesisBMC gastroenterology2026
Procedural efficiency and safety of traction-assisted versus conventional endoscopic submucosal dissection for gastric tumors: a meta-analysis of randomized controlled trials.
Synthesis in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEndoscopic submucosal dissection (ESD) is an effective minimally invasive treatment for superficial gastric tumors. However, it is technically demanding and often associated with prolonged procedure time and a risk of adverse events. Traction-assisted ESD (TA-ESD) has been introduced to improve submucosal visualization and procedural efficiency; however, evidence regarding its benefit over conventional ESD (C-ESD) in gastric lesions remains inconsistent. This study aimed to compare procedural efficiency, resection quality, and safety between TA-ESD and C-ESD in patients with superficial gastric tumors.
methodsWe conducted a PRISMA-compliant systematic review and meta-analysis of randomized controlled trials comparing TA-ESD with C-ESD for gastric tumors. Five electronic databases were searched through November 8, 2025. Only trials reporting intention-to-treat or modified intention-to-treat analyses were included. The primary outcome was procedure time. Secondary outcomes included en bloc resection, R0 resection, perforation, delayed bleeding, and traction-related damage to the specimen. Pooled estimates were calculated using the mean difference (MD) and risk ratio (RR). Subgroup analyses were performed based on endoscopist experience, tumor location, and tumor size.
resultsFive randomized controlled trials comprising 463 patients (228 TA-ESD and 235 C-ESD) met the inclusion criteria. TA-ESD was associated with a shorter procedure time than C-ESD (mean difference [MD] = -12.45 min, 95% CI: -20.67 to -4.23; P = 0.003); however, this finding was sensitive to leave-one-out analyses, with statistical significance lost after exclusion of either the Bi 2024 or Nagata 2021 trial. Procedure time was lower for both upper/middle-third gastric lesions (MD = -21.21 min, 95% CI: -30.26 to -12.17; P < 0.0001) and lower-third lesions (MD = -10.72 min, 95% CI: -17.79 to -3.64; P = 0.003). En bloc resection rates (risk ratio [RR] = 1.00, 95% CI: 0.98-1.02; P = 0.98) and R0 resection rates (RR = 0.99, 95% CI: 0.93-1.06; P = 0.83) were comparable between groups. There were no differences in perforation (RR = 0.52, 95% CI: 0.07-3.97; P = 0.53) or delayed bleeding (RR = 0.78, 95% CI: 0.29-2.09; P = 0.61). Traction-related specimen damage was rare, with a pooled incidence of 1.3%.
conclusionTA-ESD was associated with shorter procedure time than C-ESD, while maintaining comparable resection quality and safety. However, this association was sensitive to leave-one-out analyses and should therefore be interpreted cautiously. Furthermore, the overall certainty of evidence was limited, with three of five included trials judged to be at high risk of bias, and GRADE certainty for most secondary outcomes rated as low to very low. These limitations, together with the small number of available trials, underscore the need for further large, multicenter randomized studies using standardized traction techniques to better define the efficacy and safety of TA-ESD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.